2006). Xanthosine treatment results in extended microglia lifespan, concomitant with increased neurogenic potential of SVZ-derived cells (Walton et al. 2006). In this experimental condition, a MAC-1-saporin antibody, which depletes microglia, decreases neurogenic potential, while microglia-conditioned medium restores neurogenesis (Walton et al. 2006). A recent in vivo study suggests that microglia contribute to hippocampal neurogenesis in adrenalectomized Inhibitors,research,lifescience,medical rats (Battista et al. 2006). In this study, the number of activated microglia displaying a more ramified morphology, not full phagocytes, correlated

with increased neurogenesis and number of nestin-positive cells (Battista et al. 2006). Nevertheless, the role of microglia on adult neurogenesis

is an open question. Experimental depletion of SVZ microglia using a Mac-1 antibody Inhibitors,research,lifescience,medical conjugated to saporin did not affect numbers and proliferation of migrating neuroblasts in the SVZ in nonpathological conditions or migration of neuroblasts after striatal stroke (Heldmann et al. 2011). Several other functions are performed by microglia. A detailed discussion of microglial functions can be obtained in Ransohoff and Perry (2009). Microglia Activation and Inhibitors,research,lifescience,medical Acute CNS Disorders Morphological and molecular correlates of microglia activation Microglia are extremely sensible to minor alterations on the CNS microenvironment, even ionic disbalance and stress (Kreutzberg 1996; Sugama et al. 2007; Ransohoff and Perry 2009). These cells are activated in pathological conditions, which is reflected in both Inhibitors,research,lifescience,medical morphological and biochemical alterations on their structure (Streit et al. 1999; Ransohoff and Perry 2009). Microglia activation involves a conspicuous

change in Inhibitors,research,lifescience,medical their ramified morphology to an intermediate and amoeboid form culminating in a round morphological profile of full phagocytes (Morioka et al. 1993; Lehrmann et al. 1997; Thored et al. 2009). Concomitant with morphological alterations, microglial cells change their genetic machinery and upregulate several transcription factors (for example, NF-κB), cytoplasmic and surface molecules including MHC classes I and II, complement C3, Fc, thrombin, scavenger receptors (i.e., CD36, SR-A, CD204, SR-BI), cytokine, chemokine, CD4 and CD8 receptors, toll-like Idoxuridine receptors, and several oxidative enzymes, such as NADPH oxidase (Perry and Regorafenib cost Gordon 1987; Schroeter et al. 1994; Jander et al. 1998; Streit et al. 1999; Husemann et al. 2002; Block et al. 2007; Ransohoff and Perry 2009). An important question is which signals activate microglia in the event of tissue damage. These mechanisms are not completely clear. Nevertheless, there is experimental evidence suggesting that the release of purine nucleotides, including ATP, ADP, and UTP, by injured neurons is an important mechanism by which microglia are informed of tissue injury (Davalos et al. 2005; Nimmerjahn et al. 2005).